Showing results (591-600 of 1,447) with videos related to

Sort By:
Pageof 145
Proteomics. Clinical Applications|January 18, 2020
Quantitative Proteomics and Weighted Correlation Network Analysis of Tear Samples in Type 2 Diabetes Patients Complicated with Dry EyeXinrong Zou, Pei Zhang, Yi Xu, et al.
Proteomics. Clinical Applications|March 31, 2020
Salivary Microbiome Shifts in Response to Periodontal Treatment OutcomeDavid Greenwood, Beral Afacan, Gulnur Emingil, et al.
Proteomics. Clinical Applications|October 24, 2020
Proteome Analyses Reveal S100A11, S100P, and RBM25 Are Tumor Biomarkers in Colorectal CancerAi-Jun Guo, Feng-Jie Wang, Qiang Ji, et al.
Proteomics. Clinical Applications|October 17, 2020
MALDI-IMS as a Tool to Determine the Myocardial Response to Syndecan-2-Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic CardiomyopathyKathleen Pappritz, Oliver Klein, Fengquan Dong, et al.
Proteomics. Clinical Applications|December 24, 2018
Integrative Clustering in Mass Spectrometry Imaging for Enhanced Patient StratificationBenjamin Balluff, Achim Buck, Marta Martin-Lorenzo, et al.
Proteomics. Clinical Applications|November 29, 2018
iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric CancerZhen Jiang, Chenghua Zhang, Li Gan, et al.
Proteomics. Clinical Applications|February 21, 2018
Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS AnalysisYing Liu, Yi-Ran Tan, Wen-Wen Sun, et al.
Proteomics. Clinical Applications|September 5, 2014
Biomarker discovery in asthma and COPD by proteomic approachesRossana Rossi, Antonella De Palma, Louise Benazzi, et al.
Proteomics. Clinical Applications|August 30, 2014
A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controlsClaudia Landi, Elena Bargagli, Alfonso Carleo, et al.
Proteomics. Clinical Applications|December 10, 2014
Role of phosphoproteomics in the development of personalized cancer therapiesPedro R Cutillas
Pageof 145